Oliver Sexton
InvestorInvestment Director, Engineering Biology at UK Innovation & Science Seed Fund
London, England, United Kingdom
About
Oliver Sexton joined Midven in April 2014 to manage the UK Innovation & Science Seed Fund's engineering biology investments. He previously oversaw commercialisation of bioengineering and medical technologies at Imperial Innovations and served on the board of oncology company Acublate Ltd, with earlier commercial and partnering roles at Ark Therapeutics, biotech buy-side analysis, and pharma strategy consulting. He holds a BSc in Molecular Biology/Biotechnology and an MSc in Plant Science from Bristol University.
Invests in
BiotechDeep Tech
Experience
- Future Planet CapitalIC membercurrent2014 — present
- Future Planet CapitalInvestment Directorcurrent2014 — present
- CamGene TherapeuticsBoard Membercurrent2025 — present
- Ternary TherapeuticsBoard observercurrent2026 — presentLondon Area, United Kingdom
- HutanBioBoard Observercurrent2024 — present
- ikarovecDirectorcurrent2019 — present
- AntiverseBoard Observercurrent2021 — present
- twigBoard Observercurrent2022 — present
- Pencil Biosciences LimitedBoard Observercurrent2022 — present
- UK Innovation & Science Seed FundInvestment Directorcurrent2014 — presentLondon
- TropicInvestorcurrent2017 — present
- SOLASTA BioBoard Observercurrent2021 — present
- Imperial InnovationsHead Bio Engineering2010 — 2014
Education
- University of BristolMolecular Biology
- University of NottinghamPhD: Bioremediation
Skills & more
ExitsBoard of DirectorsMergers & Acquisitions (M&A)Investment AnalysisInvestment ComplianceFundraisingLicensingBoard DevelopmentBrand DevelopmentInvestmentsBiotechnologyVenture Capital
+7 more
LifesciencesCommercializationBusiness StrategyBiopharmaceuticalsStart-upsManagementPharmaceutical Industry- FCA Investment Manager — Financial Conduct Authority
From Oliver's professional profile.
Same school
Also attended University of Bristol130
Chris BischoffInvestment Team at General CatalystSaran DaviesInvestor at Moonfire VenturesThomas RubensInvestor at DN CapitalIgnacio García LeónEntrepreneur in Residence at FJ LabsAnnabel StoddartOffice Manager and Executive Assistant at Medical Excellence CapitalMichael PatersonCo-founder & former CTO at Asymmetric Capital Partners
+ 124 more
Also attended University of Nottingham110
Richard LeeInvestor at MedicxiMillan SuriPrincipal at Episode1Kieran RafterPrincipal at Marlin Equity PartnersTim SchmidtVice President, Fund Finance at Northpond VenturesRohan OzaCo-Founder & Managing Partner at CAVU Consumer PartnersSam RickardInvestor at Mercuri.vc
+ 104 more
Shared employers
Also worked at CamGene Therapeutics1
Also worked at Ternary Therapeutics1
Also worked at Antiverse2
Also worked at UK Innovation & Science Seed Fund7
Ed PhillipsManaging Director, Global at Future Planet CapitalAlexander LeighInvestment Director Defence & Security at UK Innovation & Science Seed FundTony RavenChair of Board and Consultation Committee at UK Innovation & Science Seed FundJohn TingayInvestor at UK Innovation & Science Seed FundMassimo NoroInvestor at UK Innovation & Science Seed FundTim IrishInvestor at UK Innovation & Science Seed Fund
+ 1 more
Investments
Board seats
Acublate Ltd
Per the firm's website.
Colleagues at UK Innovation & Science Seed Fund
Alexander Leigh
Investment Director Defence & Security at UK Innovation & Science Seed Fund
Alison Campbell
Investor at UK Innovation & Science Seed Fund
Andrew Muir
Investment Director at UK Innovation & Science Seed Fund
Betty Bonnardel
Investor at UK Innovation & Science Seed Fund
Dr Colin Story
Investor at UK Innovation & Science Seed Fund
Dr Peter Hamley
Investor at UK Innovation & Science Seed Fund
Eddie Alleyn
Investor at UK Innovation & Science Seed Fund
Hassan Mahmudul
Investment Manager at UK Innovation & Science Seed Fund

.jpg)



























